Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 7
2011 28
2012 23
2013 23
2014 22
2015 23
2016 28
2017 30
2018 30
2019 13
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Results by year
Filters applied: . Clear all
Page 1
Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
Martino RB, et al. Transplant Proc 2018. PMID 29661431
BACKGROUND: The Model for End-Stage Liver Disease (MELD) system reliably predicts mortality in cirrhotic patients. However, the etiology of liver disease and presence of portal vein thrombosis are not directly taken into account in MELD score. ...The aim of this study was to investigate mortality and access to transplantation regarding etiology of liver disease and portal vein thrombosis (PVT). ...
BACKGROUND: The Model for End-Stage Liver Disease (MELD) system reliably predicts mortality in cirrhotic …
Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
Lai JC, et al. Hepatology 2017. PMID 28422306 Free PMC article.
Cirrhosis is characterized by muscle wasting, malnutrition, and functional decline that confer excess mortality not well quantified by the Model for End-Stage Liver Disease (MELD) Sodium (MELDNa) score. ...Consecutive outpatients listed for liver transplantation at a single transplant center without MELD exceptions were assessed with candidate frailty measures. ...
Cirrhosis is characterized by muscle wasting, malnutrition, and functional decline that confer excess mortality not well quantified b …
Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
Remmler J, et al. Clin Gastroenterol Hepatol 2018 - Clinical Trial. PMID 28919544
BACKGROUND & AIMS: Organ allocation for liver transplantation is based on prognosis, using the model for end-stage liver disease (MELD) or MELD including serum sodium (MELD-Na) score. ...Blood level of C-reactive protein (CRP), in addition to the MELD score, associates with mortality in patients with end-stage liver disease, whereas levels of interleukin 6 (IL6) have not been systematically studied. ...
BACKGROUND & AIMS: Organ allocation for liver transplantation is based on prognosis, using the model for end-stage
Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
Schlegel V, et al. PLoS One 2017. PMID 28727814 Free PMC article.
The model of end-stage liver disease (MELD) score is a well-established tool to estimate the risk of mortality in patients with end-stage chronic liver disease. The study aims to assess the associations between PCSK9, hypocholesterinemia, liver synthesis, cholestasis, MELD score and mortality in patients with end-stage liver disease. ...
The model of end-stage liver disease (MELD) score is a well-established tool to estimate the risk of mortalit
Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
Wernly B, et al. Eur J Intern Med 2018 - Clinical Trial. PMID 29572092
PURPOSE: We aimed (i) to evaluate Model for End-stage Liver Disease excluding INR (MELD-XI) score for prediction of mortality in a cohort of critically ill patients and (ii) to investigate associations of MELD-XI with microcirculation and (iii) to evaluate microcirculation for prediction of mortality in high-risk patients, e.g., with high MELD-XI scores. ...Evaluation of associations with mortality was done by logistic regression analysis, an optimal cut-off was calculated by means of the Youden Index. ...
PURPOSE: We aimed (i) to evaluate Model for End-stage Liver Disease excluding INR (MELD-XI) score for prediction …
Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare.
Brown CL, et al. J Pain Symptom Manage 2016. PMID 27265812 Free PMC article.
CONTEXT: For end-stage liver disease (ESLD) patients, care focuses on managing the life-threatening complications of portal hypertension, causing high resource utilization. ...Index hospitalization end points included mortality, discharge to hospice, and length of stay. Postdischarge end points included all-cause mortality, rehospitalization, hospice enrollment, and days alive and out of hospital (DAOH). ...
CONTEXT: For end-stage liver disease (ESLD) patients, care focuses on managing the life-threatening complication …
Important predictor of mortality in patients with end-stage liver disease.
Kim HJ and Lee HW. Clin Mol Hepatol 2013 - Review. PMID 23837134 Free PMC article.
Prognosis is an essential part of the baseline assessment of any disease. For predicting prognosis of end-stage liver disease, many prognostic models were proposed. ...Recently, Model for end-stage liver disease (MELD) score emerged as a "modern" alternative to Child-Pugh score. The MELD score has been an important role to accurately predict the severity of liver disease and effectively assess the risk of mortality. ...
Prognosis is an essential part of the baseline assessment of any disease. For predicting prognosis of end-stage live
Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
Chirapongsathorn S, et al. J Gastroenterol Hepatol 2018. PMID 28840619
BACKGROUND AND AIM: This study aims to determine the performance of models adding C-reactive protein (CRP) and procalcitonin (PCT) to the model of end-stage liver disease (MELD) score for mortality prediction in patients hospitalized with complications of cirrhosis. ...The MELD score was predictive of 90-day mortality odds ratio (OR) 1.19 (95% confidence interval [CI] 1.09-1.32). Adding CRP and/or PCT to the MELD score improved the predictive of 90-day mortality: MELD-CRP OR 2.71 (95% CI 1.66-4.99); MELD-PCT OR 2.72 (95% CI 1.66-4.99); MELD-CRP-PCT OR 2.71 (95% CI 1.67-4.92). ...
BACKGROUND AND AIM: This study aims to determine the performance of models adding C-reactive protein (CRP) and procalcitonin (PCT) to the mo …
Beta-blockers and physical frailty in patients with end-stage liver disease.
Kuo SZ, et al. World J Gastroenterol 2018. PMID 30197482 Free PMC article.
RESULTS: Of 344 patients, 35% were female, median age was 60, median model for end stage liver disease was 15, and 53% were prescribed a BB. ...BB use was, however, significantly associated with a decreased adjusted risk of mortality (SHR 0.55; P = 0.005). CONCLUSION: In patients with cirrhosis awaiting liver transplantation, BB use is not associated with physical frailty. ...
RESULTS: Of 344 patients, 35% were female, median age was 60, median model for end stage liver disease was 15, a …
Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study.
Kim Y, et al. Medicine (Baltimore) 2019 - Clinical Trial. PMID 31702650 Free PMC article.
The use of model for end-stage liver disease with incorporation of serum-sodium (MELD-Na) with physiological indicators can be used to assess severity and differentiate therapeutic interventions.This study is aimed to determine the mean survival period and cumulative survival rate by classifying patients into high-risk and low-risk groups based on MELD-Na, a predictor of mortality in liver disease, and to investigate the mortality prognostic factors.A retrospective cohort study, which follows the STROBE checklist, was performed. 263 patients who were diagnosed with liver cirrhosis complications for the first time and hospitalized were selected as the subjects of this study. ...Based on these mortality prognostic factors, it is possible to present the factors affecting mortality in patients who were diagnosed with liver cirrhosis complications for the first time. ...
The use of model for end-stage liver disease with incorporation of serum-sodium (MELD-Na) with physiological ind …
195 results
Jump to page
Feedback